duloxetine 30 mg delayed release oral capsule
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive disorder in adults Generalized Anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults Chronic Musculoskeletal Pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major Depressive disorder (MDD) in adults (1) Generalized Anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older (1) Diabetic peripheral neuropathic pain (DPNP) in adults (1) Fibromyalgia (FM) in adults Chronic Musculoskeletal Pain in adults (1)
alembic pharmaceuticals limited
CAPSULE BLUE A 157
Related Pills
duloxetine 20 MG Delayed Release Oral Capsule
Alembic Pharmaceuticals Limited
duloxetine 30 MG Delayed Release Oral Capsule
Alembic Pharmaceuticals Limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
DULOXETINE delayed-release capsules are available as delayed release capsules in the following strengths, colors, imprints, and presentations: Features Strengths 20 mg a 30 mg a 60 mg a Body color Opaque green Opaque white Opaque green Cap color Opaque green Opaque blue Opaque blue Cap imprint A A A Body imprint 156 157 158 Presentations and NDC Codes Bottles of 30 46708-278-30 46708-279-30 46708-280-30 Bottles of 60 46708-278-60 NA NA Bottles of 90 NA 46708-279-90 46708-280-90 Bottles of 1000 46708-278-91 46708-279-91 46708-280-91 Carton of 100 46708-278-10 46708-279-10 46708-280-10 a equivalent to
DULOXETINE base 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like CAPSULE A 157